Abivax (ABVX) Other Operating Expenses (2024 - 2026)
Abivax (ABVX) posted quarterly Other Operating Expenses of -$2.0 million for Q1 2026, down 126.35% year-over-year from $7.8 million in Q1 2025, and down 100.35% quarter-over-quarter from $581.4 million in Q4 2025.
Abivax (ABVX) Other Operating Expenses (2024 - 2026) Analysis & Trends
Abivax's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$2.0 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 126.35% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at $576.5 million (up 47.43% YoY), while the FY2025 annual figure was $577.5 million, up 48.13% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$2.0 million, down from $581.4 million in the prior quarter.
- The five-year high for Other Operating Expenses was $581.4 million in Q4 2025, with the low at -$2.4 million in Q2 2024.
- The 3-year median for Other Operating Expenses is -$936781.2 (2024), against an average of $107.3 million.
- Peak annual rise in Other Operating Expenses reached 68.53% in 2025, while the deepest fall reached 129.5% in 2025.
- Abivax's Other Operating Expenses stood at $395.3 million in 2024, then surged by 47.09% to $581.4 million in 2025, then tumbled by 100.35% to -$2.0 million in 2026.
- Business Quant data shows ABVX's Other Operating Expenses at -$2.0 million in Q1 2026, $581.4 million in Q4 2025, and -$2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.05 Mn |
| Dec 31, 2025 | 581.44 Mn |
| Sep 30, 2025 | -2.15 Mn |
| Jun 30, 2025 | -762,940.83 |
| Mar 31, 2025 | -904,620.62 |
| Dec 31, 2024 | 395.29 Mn |
| Sep 30, 2024 | -936,781.24 |
| Jun 30, 2024 | -2.42 Mn |
| Mar 31, 2024 | -2.15 Mn |